
CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
57%
Total
Publications
456
Total Open
Publications
259
Total
Citations
11K
Open Access
Percentage
57%
Total
Publications
456
Total Open
Publications
259
Total
Citations
11K
Breakdown
Publisher Open
22%
Both
28%
Other Platform Open
7%
Closed
43%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 41%
95
Hybrid 25%
56
No Guarantees 34%
79
Other Platform Open
Domain 74%
118
Institution 46%
74
Other Internet 11%
18
Preprint 7%
11
Public 1%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 119 |
doaj.org OAI-PMH Repository | Institution | 46 |
DOI | Other Internet | 11 |
Unknown Repository | Other Internet | 9 |
Europe PMC | Domain | 8 |
Research Square | Preprint | 6 |
University of Groningen | Institution | 5 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 5 |
University of Michigan | Institution | 4 |
California Digital Library | Institution | 4 |